Effectiveness of oral Gabapentin in supressing nausea and vomiting after neurosurgery

Not Applicable

Completed

• Conditions: Health Condition 1: null- Prevention of nausea and vomiting

• Registration Number: CTRI/2011/06/001828
• Lead Sponsor: Sree Chitra Tirunal Institute for Medical Sciences and Technology

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 70

Inclusion Criteria

All elective adult patients posted for craniotomy who are not on gabapentin shall be recruited for this trial

Exclusion Criteria

Peditaric and pregnant patients and those operated in emergency shall be excluded from this trial

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Postoperative nausea and vomitingTimepoint: 24 hours postoperative

Secondary Outcome Measures

Name	Time	Method
Postoperative pain scoresTimepoint: 24 hours postoperative